Literature DB >> 11384714

Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants.

K G Chandy1, M Cahalan, M Pennington, R S Norton, H Wulff, G A Gutman.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11384714     DOI： 10.1016/s0041-0101(01)00120-9

Source DB:  PubMed          Journal:  Toxicon        ISSN： 0041-0101            Impact factor:   3.033


× No keyword cloud information.
  18 in total

1.  Design and synthesis of type-III mimetics of ShK toxin.

Authors:  Jonathan B Baell; Andrew J Harvey; Raymond S Norton
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

2.  Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel.

Authors:  Kunqian Yu; Wei Fu; Hong Liu; Xiaomin Luo; Kai Xian Chen; Jianping Ding; Jianhua Shen; Hualiang Jiang
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

Review 3.  K+ channels as targets for specific immunomodulation.

Authors:  K George Chandy; Heike Wulff; Christine Beeton; Michael Pennington; George A Gutman; Michael D Cahalan
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

4.  Permeation and block of the Kv1.2 channel examined using brownian and molecular dynamics.

Authors:  Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

5.  Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.

Authors:  M W Pennington; C Beeton; C A Galea; B J Smith; V Chi; K P Monaghan; A Garcia; S Rangaraju; A Giuffrida; D Plank; G Crossley; D Nugent; I Khaytin; Y Lefievre; I Peshenko; C Dixon; S Chauhan; A Orzel; T Inoue; X Hu; R V Moore; R S Norton; K G Chandy
Journal:  Mol Pharmacol       Date:  2009-01-02       Impact factor: 4.436

Review 6.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

7.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

Review 8.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

9.  Sequi Ad Maius Bonum; Targeting Ion Channels in the Lung.

Authors:  Daniel Bakowski; Andrew J Wood; Anant B Parekh
Journal:  Function (Oxf)       Date:  2020-12-21

Review 10.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.